Compounds > thymidine
Page last updated: 2024-08-17

thymidine and palbociclib

thymidine has been researched along with palbociclib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barvian, MR; Brodfuehrer, J; Choi, C; Fry, DW; Harvey, PJ; Keller, PR; McNamara, DJ; Repine, JT; Sheehan, DJ; Sherry, D; Toogood, PL; VanderWel, SN; Zhou, H; Zhu, T1
Affolter, T; Buckman, D; Christensen, JG; Cullinane, C; Fahey, NR; Kuszpit, K; Lappin, PB; Li, W; Lira, ME; Nichols, T; O'Brien, P; Painter, CL; Spilker, M; Wong, A; Yan, Z; Zasadny, K; Zhang, CC; Zhang, Q1
Basuli, F; Doroshow, JH; Hollingshead, MG; Jacobs, PM; James, A; Kalen, JD; Riffle, LA; Sanders, C; Shi, J; Tatum, JL; Thang, L1

Other Studies

3 other study(ies) available for thymidine and palbociclib

ArticleYear
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.
    Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7

    Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; G1 Phase; Humans; Male; Piperazines; Proto-Oncogene Proteins; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thymidine

2005
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Mar-01, Volume: 18, Issue:5

    Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Dideoxynucleosides; Disease Models, Animal; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Piperazines; Positron-Emission Tomography; Pyridines; Thymidine; Xenograft Model Antitumor Assays

2012
3'-[
    Journal of translational medicine, 2022, 08-18, Volume: 20, Issue:1

    Topics: Animals; Biomarkers; Cell Line, Tumor; Dideoxynucleosides; Humans; Mice; Piperazines; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pyridines; Temozolomide; Thymidine; Urinary Bladder Neoplasms

2022